drugset / Trial / NCT00133198
Efficacy and Safety of Pramipexole Compared to Placebo in the Treatment of Restless Legs Syndrome (RLS)
RandomizedParallel-groupDouble-blindTreatment
Summary
A 12 week clinical trial was conducted in the United States in order to compare pramipexole (Mirapex®) versus placebo for the ability to reduce the symptoms of restless legs syndrome in adult subjects.
Timeline
- Start
- 2004-04
- Primary completion
- 2005-02
- Completion
- 2005-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pramipexole | Unknown | 0.25 mg | Oral |
| Subject | Pramipexole | Unknown | 0.5 mg | Oral |
| Subject | Pramipexole | Unknown | 0.75 mg | Oral |